about
An extensive evaluation of read trimming effects on Illumina NGS data analysisDeveloping genomic knowledge bases and databases to support clinical management: current perspectivesChallenges to Implementation of Global Translational Collaboration PlatformsEthical considerations of research policy for personal genome analysis: the approach of the Genome Science Project in JapanIntra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome AtlasClinical integration of next generation sequencing: coverage and reimbursement challenges.Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS.What if we had whole-genome sequence data for millions of individuals?LFCseq: a nonparametric approach for differential expression analysis of RNA-seq data.Simultaneous digital quantification and fluorescence-based size characterization of massively parallel sequencing librariesPatient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century.Missing genetic risk in neural tube defects: can exome sequencing yield an insight?Bayesian models for syndrome- and gene-specific probabilities of novel variant pathogenicity.Enhanced methods for local ancestry assignment in sequenced admixed individuals.Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing.Summarizing polygenic risks for complex diseases in a clinical whole-genome reportPART of the WHOLE: A Case Study in Wellness-Oriented Personalized Medicine.DaMold: A data-mining platform for variant annotation and visualization in molecular diagnostics research.Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare SettingsHow can psychological science inform research about genetic counseling for clinical genomic sequencing?A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairsRecognizing familial myeloid leukemia in adults.High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.Personalized genomic disease risk of volunteers.Better tests, better care: improved diagnostics for infectious diseases.Applications of high-throughput DNA sequencing to benign hematologyCanadian guideline on genetic screening for hereditary renal cell cancersApplication of cancer genomics to solve unmet clinical needs.Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies.Genomic medicine, health information technology, and patient care.LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias."Use it or lose it" as an alternative approach to protect genetic privacy in personalized medicine.Clinical application of high-throughput genomic technologies for treatment selection in breast cancer.Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective.Translating next generation sequencing to practice: opportunities and necessary steps.Genetic testing for inherited ocular disease: delivering on the promise at last?Next-generation sequencing in schizophrenia and other neuropsychiatric disorders.
P2860
Q21559489-9F9AFE67-96A8-46F0-844C-66669D7A551CQ28249073-0B79D472-519F-45E7-AD4E-29A07567A19EQ28602387-9A7D15FC-4A8C-4F36-ACF6-7E2ED339CD3CQ28607430-81F11349-1699-45A7-A336-D20D91422725Q28650140-0396E1C2-2D93-4C04-B9AA-328D5EB4BB31Q30355277-EBA146EE-A4B1-475A-84F3-9829D3D8A192Q30591763-75461C61-4A91-4FFE-8A5A-A1CBF366D84FQ30626900-9BDDEB3B-B39A-4115-9AE4-2ECCB375AD67Q30667828-78274E14-50ED-42F9-AB92-F044750ADD87Q30882831-A89018DC-DCC3-4D0F-BFD7-078CA3CF3E92Q33599067-95273BE7-26A8-4811-B140-C5E260FACBE9Q34037747-02413952-090E-44AC-AE3F-43D1E4ED92E5Q34429995-89FC2AB1-0F27-452C-90AF-A7B7C338D964Q35021365-82458B7E-544A-4F36-A06B-9EF73FB56872Q35151724-CB2BD35A-9B6B-4609-BA34-E117E51C0C03Q35736188-7FCEC9ED-FF4F-4C62-8CAF-DFBC25AED8E3Q35894536-993C7E77-3C9A-4B1A-A8C3-9EFA48818D4FQ35925229-FD3FF38C-59B2-4B17-8CAF-D3387DA11EA3Q35990450-19320200-A1B7-40B6-A24D-09E43E3F7004Q36302364-E939D912-B2D8-4760-9ACA-6EFBB1697A6EQ36342845-7E55E49D-6127-4917-A494-BE3E3342FD24Q36367741-15499649-0802-4344-86B8-16A46D57671BQ36649146-6C58B82A-A3ED-4AF3-A2A4-C9E561C44081Q36983135-C52DCD6F-67DC-4337-A6A4-601C6789D793Q37073883-09D1BF41-C003-40F8-B659-E68E769DA619Q37075688-F50982D4-FC3D-41CF-BD30-40D27EE592FCQ37240475-B43D95A0-0A0A-42E6-9CFF-6BC52C3F46F9Q37287115-CA3DE7AE-B516-430B-9637-CA838EB8AB48Q37334703-F7F5C016-4305-43C2-911F-B884AAA4C40AQ37371645-DABEF983-6229-4415-A93B-48CD5D1166E4Q37500880-41542D95-41ED-4CC5-A956-1B1140EB88ADQ37590819-D40B720D-FC4D-4D72-9FEA-7D26DBEB5DFBQ37649261-B7777D24-7914-4032-B073-B1E8BC6D8A07Q37665490-608549F2-4CEF-4B38-95F0-28EC8B5606FCQ37674771-379E8CAB-B10E-4AB4-9F4D-5882E6977D5FQ37691245-4E77D050-6864-4630-8118-98C2226FED66Q38092689-31EF87D5-BC4B-4B95-846D-128C7388C5F0Q38114641-23F320B9-87F6-4FF4-B0E2-60C3688934A9Q38120835-4372B087-68B6-4E0F-B348-771E15F227D0Q38153345-E9ACB8ED-4EE7-43D4-AB20-D46699C1B8EC
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Next-generation sequencing in the clinic: are we ready?
@en
Next-generation sequencing in the clinic: are we ready?
@nl
type
label
Next-generation sequencing in the clinic: are we ready?
@en
Next-generation sequencing in the clinic: are we ready?
@nl
prefLabel
Next-generation sequencing in the clinic: are we ready?
@en
Next-generation sequencing in the clinic: are we ready?
@nl
P2860
P50
P356
P1476
Next-generation sequencing in the clinic: are we ready?
@en
P2093
Ron Zimmern
Sharon E Plon
P2860
P2888
P304
P356
10.1038/NRG3357
P577
2012-11-01T00:00:00Z